Form 4: HealthEquity Insider Acquires Shares, Options
Insider Ownership Disclosure
Stephen Neeleman, Founder and Vice Chairman of HealthEquity, reported the acquisition of common stock through restricted stock units and disclosed existing stock options.
Summary
- Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc. (HQY), reported changes in his beneficial ownership.
- Acquired 15,915 shares of common stock through restricted stock units (RSUs) on March 25, 2026, with a vesting schedule commencing April 1, 2027, at 25% of the initial award, followed by 6.25% quarterly for twelve quarters.
- Acquired an additional 23,860 shares of common stock through restricted stock units (RSUs) on March 25, 2026, which vested on the same date.
- Direct beneficial ownership after these transactions includes 126,659 shares and 150,519 shares.
- Indirect beneficial ownership includes 409,735 shares held by the Stephen and Christine Neeleman Trust, 140,000 shares by his spouse (beneficial ownership disclaimed), and 203,000 shares by Neeleman Family Holdings, LLC (beneficial ownership disclaimed except for pecuniary interest).
- Disclosed existing stock options: 19,897 options at an exercise price of $41.28 (expiring March 27, 2027), 14,228 options at $61.72 (expiring March 27, 2028), and 15,337 options at $73.61 (expiring March 26, 2029), all immediately exercisable.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral disclosure, typical for insider equity compensation and ownership reporting, without inherently positive or negative implications for the company's operational performance.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insiders, providing transparency into executive and director equity holdings and compensation structures. These transactions are typical for executives receiving equity as part of their compensation package.
Related Party Transactions
- Indirect beneficial ownership includes shares held by the Stephen and Christine Neeleman Trust, shares held by the reporting person's spouse, and shares held by Neeleman Family Holdings, LLC, where the reporting person is the manager.
Stakeholder Impact
- Shareholders gain transparency into the equity holdings and compensation of a key executive, Stephen Neeleman, which is standard practice for corporate governance.
Next Steps
- Vesting of 15,915 restricted stock units will commence on April 1, 2027, with subsequent quarterly vesting over twelve quarters.
Key Dates
| Date | Description |
|---|---|
| 03/25/2026 | Transaction date for acquisition of restricted stock units. |
| 03/27/2026 | Signature date of the reporting person. |
| 04/01/2027 | First vesting date for 25% of the 15,915 restricted stock units. |
| 03/27/2027 | Expiration date for 19,897 stock options with an exercise price of $41.28. |
| 03/27/2028 | Expiration date for 14,228 stock options with an exercise price of $61.72. |
| 03/26/2029 | Expiration date for 15,337 stock options with an exercise price of $73.61. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to compensation and beneficial ownership. It does not provide sufficient new information regarding the company's operational performance, strategic direction, or financial health to warrant a change in investment stance. Investors should consider this a standard disclosure and maintain their current position based on broader company fundamentals.
Keywords
HealthEquity, HQY, Stephen Neeleman, Form 4, Insider Trading, Restricted Stock Units, Stock Options, Beneficial Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.